Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina
- Autores
- Rodero, Laura; Davel, Graciela Odelsia; Córdoba, Susana; Soria, Marcelo; Canteros, Cristina; Hochenfellner, F.
- Año de publicación
- 1999
- Idioma
- español castellano
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Fil: Rodero, L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Davel, G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Córdoba, S. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Soria, M. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Canteros, C. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Hochenfellner, F. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
A multicenter study was performed between April and September 1998 with the participation of 12 medical centers located in 8 different provinces and in the capital city of Argentina. The aim of this study was to determine the species distribution and the antifungal susceptibility profile of isolates causing nosocomial fungal infections. All the fungal isolates obtained were sent to the Mycology Department for reference identification and antifungal susceptibility testing. Eighty-nine isolates were received from different clinical specimens. The distribution of species obtained was C. albicans (50.6%), C. tropicalis (22.5%), C. parapsilosis (20.2%), C. krusei (3.4%), C. glabrata (2.2%) and Debaryomyces hansenii (1.1%). Most of the isolates (85/88) had MICs for amphotericin B < or = 1 microgram/ml, C. krusei showed resistance to fluconazole but was dose dependent susceptible to itraconazole, C. glabrata (2/2) were resistant against both drugs, most of the isolates of C. albicans, C. tropicalis and C. parapsilosis were susceptible to these triazole drugs. These data showed a different distribution of Candida species compared with results obtained in other countries. The low frequency of appearance of C. krusei and C. glabrata in our country suggests a reduced selective pressure by triazoles. - Fuente
- Revista argentina de microbiología 1999; 31(3):114-119
- Materia
-
Antifúngicos
Argentina
Candidiasis
Infección Hospitalaria
Fluconazol
Humanos
Incidencia
Itraconazol
Pruebas de Sensibilidad Microbiana - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- none
- Repositorio
- Institución
- Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
- OAI Identificador
- oai:sgc.anlis.gob.ar:Publications/123456789/1882
Ver los metadatos del registro completo
id |
SGCANLIS_ee684d826de30d2c25a5d41240c7d72f |
---|---|
oai_identifier_str |
oai:sgc.anlis.gob.ar:Publications/123456789/1882 |
network_acronym_str |
SGCANLIS |
repository_id_str |
a |
network_name_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
spelling |
Estudio multicéntrico sobre candidiasis nosocomial en la República ArgentinaMulticenter study on nosocomial candidiasis in the Republic of ArgentinaRodero, LauraDavel, Graciela OdelsiaCórdoba, SusanaSoria, MarceloCanteros, CristinaHochenfellner, F.AntifúngicosArgentinaCandidiasisInfección HospitalariaFluconazolHumanosIncidenciaItraconazolPruebas de Sensibilidad MicrobianaFil: Rodero, L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Davel, G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Córdoba, S. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Soria, M. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Canteros, C. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Hochenfellner, F. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.A multicenter study was performed between April and September 1998 with the participation of 12 medical centers located in 8 different provinces and in the capital city of Argentina. The aim of this study was to determine the species distribution and the antifungal susceptibility profile of isolates causing nosocomial fungal infections. All the fungal isolates obtained were sent to the Mycology Department for reference identification and antifungal susceptibility testing. Eighty-nine isolates were received from different clinical specimens. The distribution of species obtained was C. albicans (50.6%), C. tropicalis (22.5%), C. parapsilosis (20.2%), C. krusei (3.4%), C. glabrata (2.2%) and Debaryomyces hansenii (1.1%). Most of the isolates (85/88) had MICs for amphotericin B < or = 1 microgram/ml, C. krusei showed resistance to fluconazole but was dose dependent susceptible to itraconazole, C. glabrata (2/2) were resistant against both drugs, most of the isolates of C. albicans, C. tropicalis and C. parapsilosis were susceptible to these triazole drugs. These data showed a different distribution of Candida species compared with results obtained in other countries. The low frequency of appearance of C. krusei and C. glabrata in our country suggests a reduced selective pressure by triazoles.Asociación Argentina de Microbiología1999-07info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf0325-7541http://sgc.anlis.gob.ar/handle/123456789/1882Revista argentina de microbiología 1999; 31(3):114-119reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLIS#PLACEHOLDER_PARENT_METADATA_VALUE#datasetsRevista Argentina de microbiologianoneinfo:eu-repo/semantics/openAccessspa2025-09-04T11:17:52Zoai:sgc.anlis.gob.ar:Publications/123456789/1882Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-09-04 11:17:52.268Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false |
dc.title.none.fl_str_mv |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina Multicenter study on nosocomial candidiasis in the Republic of Argentina |
title |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina |
spellingShingle |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina Rodero, Laura Antifúngicos Argentina Candidiasis Infección Hospitalaria Fluconazol Humanos Incidencia Itraconazol Pruebas de Sensibilidad Microbiana |
title_short |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina |
title_full |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina |
title_fullStr |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina |
title_full_unstemmed |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina |
title_sort |
Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina |
dc.creator.none.fl_str_mv |
Rodero, Laura Davel, Graciela Odelsia Córdoba, Susana Soria, Marcelo Canteros, Cristina Hochenfellner, F. |
author |
Rodero, Laura |
author_facet |
Rodero, Laura Davel, Graciela Odelsia Córdoba, Susana Soria, Marcelo Canteros, Cristina Hochenfellner, F. |
author_role |
author |
author2 |
Davel, Graciela Odelsia Córdoba, Susana Soria, Marcelo Canteros, Cristina Hochenfellner, F. |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
Antifúngicos Argentina Candidiasis Infección Hospitalaria Fluconazol Humanos Incidencia Itraconazol Pruebas de Sensibilidad Microbiana |
topic |
Antifúngicos Argentina Candidiasis Infección Hospitalaria Fluconazol Humanos Incidencia Itraconazol Pruebas de Sensibilidad Microbiana |
dc.description.none.fl_txt_mv |
Fil: Rodero, L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. Fil: Davel, G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. Fil: Córdoba, S. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. Fil: Soria, M. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. Fil: Canteros, C. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. Fil: Hochenfellner, F. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. A multicenter study was performed between April and September 1998 with the participation of 12 medical centers located in 8 different provinces and in the capital city of Argentina. The aim of this study was to determine the species distribution and the antifungal susceptibility profile of isolates causing nosocomial fungal infections. All the fungal isolates obtained were sent to the Mycology Department for reference identification and antifungal susceptibility testing. Eighty-nine isolates were received from different clinical specimens. The distribution of species obtained was C. albicans (50.6%), C. tropicalis (22.5%), C. parapsilosis (20.2%), C. krusei (3.4%), C. glabrata (2.2%) and Debaryomyces hansenii (1.1%). Most of the isolates (85/88) had MICs for amphotericin B < or = 1 microgram/ml, C. krusei showed resistance to fluconazole but was dose dependent susceptible to itraconazole, C. glabrata (2/2) were resistant against both drugs, most of the isolates of C. albicans, C. tropicalis and C. parapsilosis were susceptible to these triazole drugs. These data showed a different distribution of Candida species compared with results obtained in other countries. The low frequency of appearance of C. krusei and C. glabrata in our country suggests a reduced selective pressure by triazoles. |
description |
Fil: Rodero, L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. |
publishDate |
1999 |
dc.date.none.fl_str_mv |
1999-07 |
dc.type.none.fl_str_mv |
info:ar-repo/semantics/articulo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
0325-7541 http://sgc.anlis.gob.ar/handle/123456789/1882 |
identifier_str_mv |
0325-7541 |
url |
http://sgc.anlis.gob.ar/handle/123456789/1882 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# datasets Revista Argentina de microbiologia |
dc.rights.none.fl_str_mv |
none info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
none |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Asociación Argentina de Microbiología |
publisher.none.fl_str_mv |
Asociación Argentina de Microbiología |
dc.source.none.fl_str_mv |
Revista argentina de microbiología 1999; 31(3):114-119 reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" instacron:ANLIS |
reponame_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
collection |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
instname_str |
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
instacron_str |
ANLIS |
institution |
ANLIS |
repository.name.fl_str_mv |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
repository.mail.fl_str_mv |
biblioteca@anlis.gov.ar |
_version_ |
1842344422680821760 |
score |
12.623145 |